Related Experiment Video
Updated: Aug 11, 2026

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells
Published on: April 14, 2010
Sequence, expression and function of an mRNA encoding a soluble form of the human interleukin-6 receptor (sIL-6R)
J A Lust1, D F Jelinek, K A Donovan
1Department of Laboratory Medicine, Mayo Clinic, Rochester, MN.
Abstract:
Soluble receptors have been shown to be potent immunomodulators of their respective ligands. Since IL-6 is a central growth factor for myeloma cells, an sIL-6R may modulate IL-6 activity. We have previously reported a novel IL-6R mRNA from myeloma cells that exhibits a 94-nt deletion of the entire transmembrane domain from codons 356 (G-TG) to 387 (AG-G). The transmembrane domain deletion results in a shift in the translational reading frame with the insertion of 10 new amino acids followed by a stop codon. Sequence analysis shows the ligand-binding domain of the sIL-6R to be identical to that of the membrane-bound IL-6R up to the transmembrane domain deletion. The sIL-6R cDNA was expressed in QT-6 fibroblasts and PA-1 ovarian cells using the expression vector pCDM8. Supernates were immunoprecipitated with anti-IL-6R antibody and cells transfected with the sIL-6R cDNA produced a single band with a molecular weight of 50-55 kDa. This molecular weight corresponds to the size of the sIL-6R protein observed in normal human urine. Supernates were collected from mock or sIL-6R transfected PA-1 cells after 48 hours and assayed for their ability to stimulate or suppress the growth of an IL-6 dependent cell line, ANBL-6. Soluble IL-6R alone had no effect on the growth of the ANBL-6 cells. However, the growth of ANBL-6 cells by sIL-6R was potentiated in the presence of IL-6 and could be blocked by anti-IL-6 antibody. The above results suggest that, in the presence of IL-6, sIL-6R associates with gp130 leading to signal transduction and cell growth.
Insights
A novel soluble interleukin-6 receptor (sIL-6R) from myeloma cells modulates IL-6 activity. In the presence of IL-6, sIL-6R promotes myeloma cell growth by associating with gp130.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- Soluble receptors are key immunomodulators.
- Interleukin-6 (IL-6) is a critical growth factor for myeloma cells.
- A novel IL-6 receptor (IL-6R) mRNA with a transmembrane domain deletion was identified in myeloma cells.
Purpose of the Study:
- To investigate the functional role of the novel soluble IL-6 receptor (sIL-6R) in modulating IL-6 activity.
- To determine if sIL-6R influences the growth of IL-6 dependent myeloma cells.
Main Methods:
- Expression of sIL-6R cDNA in QT-6 fibroblasts and PA-1 ovarian cells.
- Immunoprecipitation of sIL-6R from cell supernatants.
- Assay of sIL-6R's effect on the growth of the IL-6 dependent cell line ANBL-6 in the presence and absence of IL-6.
Main Results:
- Transfected cells produced a 50-55 kDa sIL-6R protein, consistent with urinary sIL-6R.
- Soluble IL-6R alone did not affect ANBL-6 cell growth.
- sIL-6R potentiated IL-6-induced ANBL-6 cell growth, which was blocked by anti-IL-6 antibody.
Conclusions:
- The novel sIL-6R functions as an immunomodulator of IL-6 activity.
- In the presence of IL-6, sIL-6R associates with gp130, leading to signal transduction and promoting myeloma cell growth.
Related Concept Videos
MicroRNAs
RNA Splicing
RNA Splicing
Leaky Scanning
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
MicroRNAs

